quinelorane has been researched along with Autosomal Dominant Juvenile Parkinson Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hiratochi, M; Ijiro, T; Kaidoh, K; Oana, F; Suzuki, T; Tsuchioka, A; Yamauchi, Y | 1 |
| Bendor, J; Bonab, AA; Elmaleh, DR; Fahey, MA; Fischman, AJ; Goodrich, C; Goulet, M; Lin, Z; Livni, E; Madras, BK; Meltzer, PC | 1 |
| Goulet, M; Madras, BK | 1 |
3 other study(ies) available for quinelorane and Autosomal Dominant Juvenile Parkinson Disease
| Article | Year |
|---|---|
Duration of drug action of dopamine D2 agonists in mice with 6-hydroxydopamine-induced lesions.
Topics: Animals; Antiparkinson Agents; Apomorphine; Azepines; Benzothiazoles; Cabergoline; Corpus Striatum; Disease Models, Animal; Dopamine Agonists; Ergolines; Indoles; Injections, Intraventricular; Male; Mice; Motor Activity; Oxidopamine; Parkinsonian Disorders; Pramipexole; Quinolines; Receptors, Dopamine D2; Tetrahydronaphthalenes; Thiophenes | 2015 |
Dopamine transporter (DAT) inhibitors alleviate specific parkinsonian deficits in monkeys: association with DAT occupancy in vivo.
Topics: Animals; Cocaine; Dopamine Plasma Membrane Transport Proteins; Female; Macaca fascicularis; Male; Parkinsonian Disorders; Quinolines; Receptors, Dopamine D2; Receptors, Dopamine D3 | 2006 |
D(1) dopamine receptor agonists are more effective in alleviating advanced than mild parkinsonism in 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-treated monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Behavior, Animal; Benzazepines; Dopamine Agents; Dopamine Agonists; Dyskinesia, Drug-Induced; Female; Macaca fascicularis; Male; Motor Activity; Motor Skills; Oxazines; Parkinsonian Disorders; Phenanthridines; Quinolines; Receptors, Dopamine D1 | 2000 |